The Effect of Preoperative Gabapentin on Postoperative Pain Control and Analgesic Requirements Following Bariatric Surgery

N/ANot Yet RecruitingNCT07169006

Ain Shams University102 enrolled

Overview

The importance of bariatric anesthesia and analgesia research cannot be ignored as it can inform and improve the perioperative protocols for other patients with morbid obesity irrespective of the surgical procedures they are undergoing

Among various postoperative complications, pain is the main adverse event experienced by patients. Good control of postoperative pain is an important factor for reducing early postoperative complications such as pulmonary embolism, deep vein thrombosis, ileus, and respiratory infections, and for decreasing length of stay, lowering costs, and increasing patient satisfaction

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

SINGLE

Enrollment

102

Conditions

Bariatric Surgery Analgesia

Interventions

Group 1DRUG

Will receive a single dose of gabapentin 300 mg preoperatively before standard general anesthesia

Group 2DRUG

will receive a placebo before standard general anesthesia

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion criteria: * patients with American Society of Anesthesiologists physical status ASA I to III * both genders * Morbid obese scheduled for bariatric surgery Exclusion Criteria: * patients with impaired liver or kidney disease * patients with history of hypersensitivity to gabapentin * patients with history of alcohol abuse, chronic pain or frequent use of analgesic * patients with uncontrolled medical disease

Outcomes

Primary Outcomes

Comparing pain score between the two groups during 1st postoperative 24 hours using visual analogue score (VAS

Time frame: 24 hours postoperative

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.